St. Louis, Missouri, June 16, 2026 – Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering, today announced three strategic appointments within its Business Development function. These additions reinforce the company’s commercial capabilities as it continues its transformation and positions the business for long-term growth.
Codis has appointed Pedro Fernandes Botas as Business Development Director, Europe. With a strong commercial background across Lotus Pharmaceutical, Faes Farma, Bene, Labatec Pharma, and Hovione, Mr. Botas brings deep expertise in building strategic partnerships and opening new market opportunities across the region. His role is focused on expanding Codis’ European presence in spray drying and related particle‑engineering services while supporting the evolution of the company’s commercial approach.
The company has also appointed Suzanne Brady, Ph.D., as Business Development Director, U.S. Dr. Brady brings extensive experience from Hovione, Mikart, Serán Bioscience, and Lonza, along with a proven record of driving commercial success and developing strategic alliances. Her remit centers on identifying and developing new business opportunities in the U.S. pharmaceutical spray drying market and contributing to Codis’ broader commercial strategy.
In addition, Derek Deckrader has joined Codis as Business Development Director, U.S., based in St. Louis. Mr. Deckrader brings significant commercial experience from Pharma Tech, Martin Bauer, and Sensient, with a strong track record in client engagement and solution development. Unlike the spray‑drying‑focused roles of Pedro and Suzanne, Derek’s responsibilities extend across Codis’ full US portfolio, emphasizing aqueous spray drying, microencapsulation and granulation technologies, value-added ingredient solutions for the vitamins, minerals, and supplements (VMS) industry, and finished dose manufacturing services that enable end-to-end product development and commercialization. His appointment strengthens the company’s ability to serve a wider range of customers across its full portfolio.
“These appointments significantly strengthen our global commercial organization,” said Steve Facer, SVP Sales & Marketing. “Pedro, Suzanne and Derek each bring exceptional industry experience, strong commercial acumen, and a shared commitment to advancing Codis’ growth ambitions. Their leadership will play a central role as we continue to reshape the business and expand our presence across the US and Europe.”
Together, these appointments reflect Codis’ accelerating growth trajectory and its commitment to building a world‑class commercial organization positioned for sustained expansion in the U.S. and Europe. As customer demand continues to rise and commercial activity increases, Codis is also preparing to bring additional spray‑drying capacity online through a forthcoming PSD4 large-scale spray dryer, further strengthening the company’s ability to support new programs and long‑term partnerships.
About Codis
Codis is a global CDMO specializing in commercial spray drying, amorphous solid dispersions, particle engineering, and finished dose manufacturing for the pharmaceutical, consumer health, nutraceutical, and OTC sectors. With more than 400,000 sq ft of cGMP facilities in St. Louis, Missouri, Seymour, Indiana, and Haverhill, UK, Codis combines decades of regulatory expertise and manufacturing strength under one brand. Learn more at www.codis.com.